164 related articles for article (PubMed ID: 38145301)
1. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
[TBL] [Abstract][Full Text] [Related]
2. Memory impairment in the D2.mdx mouse model of Duchenne muscular dystrophy is prevented by the adiponectin receptor agonist ALY688.
Bellissimo CA; Castellani LN; Finch MS; Murugathasan M; Gandhi S; Sweeney G; Abdul-Sater AA; MacPherson REK; Perry CGR
Exp Physiol; 2023 Sep; 108(9):1108-1117. PubMed ID: 37415288
[TBL] [Abstract][Full Text] [Related]
3. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
[TBL] [Abstract][Full Text] [Related]
4. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
[TBL] [Abstract][Full Text] [Related]
5. The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle.
Dubuisson N; Versele R; Davis-López de Carrizosa MA; Selvais CM; Noel L; Planchon C; Van den Bergh PYK; Brichard SM; Abou-Samra M
Cells; 2023 Aug; 12(16):. PubMed ID: 37626911
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
8. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
Sahani R; Wallace CH; Jones BK; Blemker SS
J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial creatine sensitivity is lost in the D2.
Bellissimo CA; Delfinis LJ; Hughes MC; Turnbull PC; Gandhi S; DiBenedetto SN; Rahman FA; Tadi P; Amaral CA; Dehghani A; Cobley JN; Quadrilatero J; Schlattner U; Perry CGR
Am J Physiol Cell Physiol; 2023 May; 324(5):C1141-C1157. PubMed ID: 36689672
[TBL] [Abstract][Full Text] [Related]
10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
13. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
[TBL] [Abstract][Full Text] [Related]
14. Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic
Ritter P; Nübler S; Buttgereit A; Smith LR; Mühlberg A; Bauer J; Michael M; Kreiß L; Haug M; Barton E; Friedrich O
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142754
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
16. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
[TBL] [Abstract][Full Text] [Related]
17. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice.
Morris CA; Selsby JT; Morris LD; Pendrak K; Sweeney HL
J Appl Physiol (1985); 2010 Nov; 109(5):1492-9. PubMed ID: 20847128
[TBL] [Abstract][Full Text] [Related]
18. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
[TBL] [Abstract][Full Text] [Related]
19. Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
Hinkle RT; Lefever FR; Dolan ET; Reichart DL; Dietrich JA; Gropp KE; Thacker RI; Demuth JP; Stevens PJ; Qu XA; Varbanov AR; Wang F; Isfort RJ
BMC Med; 2007 Jul; 5():18. PubMed ID: 17626629
[TBL] [Abstract][Full Text] [Related]
20. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd
Hayes HM; Angerosa J; Piers AT; White JD; Koleff J; Thurgood M; Moody J; Cheung MM; Pepe S
Oxid Med Cell Longev; 2022; 2022():5362115. PubMed ID: 35340200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
